Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunomodulators for skin cancer.

Adriana M Villa1, Brian Berman

  • 1Department of Dermatology and Cutaneous Surgery University of Miami-School of Medicine, FL, USA.

Journal of Drugs in Dermatology : JDD
|November 24, 2004
PubMed
Summary

Immunomodulators boost the immune system to fight cancer. This review focuses on their use in treating various skin cancers, including melanoma and non-melanoma skin cancers.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and safety of apomorphine in the treatment of Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials.

Therapeutic advances in neurological disorders·2026
Same author

Publisher Correction: Risk of Nonmelanoma Skin Cancer in Patients with Moderate-to-Severe Atopic Dermatitis: A United States Population-Based Study.

Dermatology and therapy·2025
Same author

Risk of Nonmelanoma Skin Cancer in Patients with Moderate-to-Severe Atopic Dermatitis: A United States Population-Based Study.

Dermatology and therapy·2025
Same author

Expert consensus-based recommendations on the use of photodynamic therapy in actinic keratosis patients.

JAAD international·2025
Same author

Red light photodynamic therapy with 10% aminolevulinic acid gel showed efficacy for treatment of superficial basal cell carcinoma in a randomized, vehicle controlled, double-blind, multicenter phase III study.

Journal of the American Academy of Dermatology·2025
Same author

Unlocking disease insights to facilitate drug development: Pharmaceutical industry-academia collaborations in inflammation and immunology.

Drug discovery today·2025

Area of Science:

  • Oncology
  • Immunology
  • Dermatology

Background:

  • Cancer therapies aim to enhance tumor antigenicity or the host immune response.
  • Immunomodulators are a class of therapeutic agents that up-regulate the immune system.

Purpose of the Study:

  • To review the current applications of immunomodulators in treating skin cancers.
  • To highlight the role of immune response modifiers in managing various dermatological malignancies.

Main Methods:

  • Literature review of therapeutic interventions for cancer immunotherapy.
  • Focus on immunomodulators and their efficacy in skin cancer treatment.

Main Results:

  • Immunomodulators are integral to cancer treatment strategies.
  • Their application spans non-melanoma skin cancer, melanoma, lymphoma, Kaposi sarcoma, and extramammary Paget's disease.

Conclusions:

  • Immunomodulators play a significant role in the immunotherapy of skin cancers.
  • Further research into immune response modifiers can optimize treatment outcomes for these conditions.

Related Experiment Videos